zolpidem has been researched along with Genetic Predisposition in 2 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozell, LB | 1 |
| Walter, NA | 1 |
| Milner, LC | 1 |
| Wickman, K | 1 |
| Buck, KJ | 1 |
| Cartwright, R | 1 |
2 other studies available for zolpidem and Genetic Predisposition
| Article | Year |
|---|---|
Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol.
Topics: Animals; Area Under Curve; Behavior, Animal; Brain; Chromosome Mapping; Chromosomes, Human, Pair 1; | 2009 |
Re: Pressman, M. Response to Rosalind Cartwright's letter to the editor. Sleep Medicine Reviews 2007; 11(4): 329-333.
Topics: Aggression; Animals; Arousal; Delta Rhythm; Expert Testimony; Genetic Predisposition to Disease; Hum | 2008 |